Published in TB and Outbreaks Week, March 20th, 2001
Although researchers had already observed that isoniazid could increase concentrations of other drugs in the bloodstream, they had not established a mechanism for this effect.
Predicting the likelihood of this interaction has become more important as TB patients have become sicker, said Z. Desta and colleagues working at Georgetown University.
"The use of isoniazid has increased over the past years, largely as a result of the co-epidemic...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.